A Case of Minimal Change Disease Superimposed on Stable Membranous Nephropathy Following the Third Dose of COVID ‐19 mRNA Vaccine in a Patient With Type 2 Diabetes

Documenti analoghi

• Minimal Change Nephrotic Syndrome Complicated by Classical Hodgkin Lymphoma During Prolonged Rituximab Maintenance Therapy: A Case Report
  di: Koshi Yamada, et al.
  Pubblicazione: (2026)
• A Novel PHEX Mutation in X‐Linked Hypophosphataemic Rickets With Reduced Expression of NaPi‐IIa and NaPi‐IIc in the Proximal Tubules: A Case Report
  di: Masahiro Muto, et al.
  Pubblicazione: (2025)
• Glomerular Galactose‐Deficient IgA1 Deposition in 192 Autopsy Cases in Japan
  di: Yoshihito Nihei, et al.
  Pubblicazione: (2025)
• Principles for Optimal Drug Selection in IgA Nephropathy—Time for Integrating Pathogenesis and Clinical Markers to Guide Therapy
  di: Yusuke Suzuki
  Pubblicazione: (2026)
• Correspondence on “New Onset of Primary Membranous Nephropathy After COVID ‐19 mRNA Vaccination in Affected Sjogren's Syndrome”
  di: Hinpetch Daungsupawong, et al.
  Pubblicazione: (2025)